Policy, Health IT

CMS is searching for a chief information security officer

The selected candidate will provide direction for the planning, coordination and control of information system security and CMS-wide privacy, according to a job posting on USAJobs.gov.

CMS is looking for a chief information security officer/director of the information security and privacy group in the Office of Information Technology, according to job posting on USAJobs.gov.

The individual selected for the position will offer direction for the planning, coordination and control of information system security and CMS-wide privacy. This includes security measures for computers, communication systems and electronic storage devices.

The chosen candidate will also provide leadership in privacy policy and assure the information security and governance strategy is in line with CMS’ business needs and long-term goals.

“The complexity of this position will require a leadership approach that is imaginative and collaborative, including the ability to work with other leaders to set the best balance between security strategies and other agency priorities,” reads the job posting.

The position is based in Baltimore, and the deadline to apply is April 19, 2019.

In other CMS news, the agency recently launched the Emergency Triage, Treat and Transport (ET3) model. Through it, CMS will continue to pay for Medicare beneficiaries’ emergency transport to a hospital ED or other destination covered under current regulations. Additionally, it will pay ambulance suppliers and providers to transport a patient to an alternate location (like a primary care provider’s office or urgent care clinic) and provide treatment in place with a practitioner, either on the scene or using telehealth.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

The ET3 model is voluntary and will have a five-year performance period. The anticipated start date is January 1, 2020, and the anticipated performance period end date is December 31, 2024.

CMS also dropped a proposed interoperability rule earlier this month, which would require government health plans and health plans sold on the federal ACA exchanges to give patients access to and control over their health data by 2020.

Photo: Jirsak, Getty Images